Sung Anthony D, Anderson Megan E, Zurakowski David, Hornicek Francis J, Gebhardt Mark C
Harvard Medial School, Boston, MA, USA.
Clin Orthop Relat Res. 2008 Oct;466(10):2519-26. doi: 10.1007/s11999-008-0407-0. Epub 2008 Aug 5.
Between 1979 and 2004, 167 patients younger than 20 years were treated surgically for humeral or femoral unicameral bone cysts with either injection of corticosteroids (steroids), curettage plus bone grafting (curettage), or a combination injection of steroids, demineralized bone matrix, and bone marrow aspirate (SDB) at Children's Hospital of Boston and Massachusetts General Hospital (mean followup, 7.3 years; range, 1 month-27 years). Outcomes included treatment failure (defined clinically as subsequent pathologic fracture or need for retreatment to prevent pathologic fracture) and complications. Information was obtained from medical records and by telephone questionnaire. After one treatment, 84% of cysts treated with steroids experienced failed treatment versus 64% with curettage and 50% with SDB. For unicameral bone cysts requiring retreatment (regardless of first treatment), 76% retreated with steroids had failed treatment versus 63% with curettage and 71% with SDB. Curettage was associated with the lowest rate of posttreatment pathologic fractures and highest rate of pain and other complications. Multivariate logistic regression indicated treatment with steroids alone and younger age were independent predictors of failure. We believe SDB is a reasonable first treatment for unicameral bone cysts in the humerus and femur in patients younger than 20 years, being less invasive yet comparable to curettage in preventing recurrence.
1979年至2004年期间,波士顿儿童医院和马萨诸塞州总医院对167例20岁以下的肱骨或股骨单房骨囊肿患者进行了手术治疗,治疗方法包括注射皮质类固醇(类固醇)、刮除加植骨(刮除术),或联合注射类固醇、脱矿骨基质和骨髓抽吸物(SDB)(平均随访7.3年;范围1个月至27年)。结果包括治疗失败(临床上定义为随后发生病理性骨折或需要再次治疗以预防病理性骨折)和并发症。通过查阅病历和电话问卷调查获取信息。一次治疗后,接受类固醇治疗的囊肿有84%治疗失败,而接受刮除术的为64%,接受SDB治疗的为50%。对于需要再次治疗的单房骨囊肿(无论首次治疗方法如何),再次接受类固醇治疗的有76%治疗失败,接受刮除术的为63%,接受SDB治疗的为71%。刮除术与治疗后病理性骨折发生率最低以及疼痛和其他并发症发生率最高相关。多因素逻辑回归分析表明,单独使用类固醇治疗和年龄较小是治疗失败的独立预测因素。我们认为,SDB是20岁以下肱骨和股骨单房骨囊肿患者合理的首选治疗方法,其侵入性较小,但在预防复发方面与刮除术相当。